After finishing at $0.15 in the prior trading day, Avenue Therapeutics Inc (NASDAQ: ATXI) closed at $0.15, down -3.34%. In other words, the price has decreased by -$0.0051 from its previous closing price. On the day, 790979 shares were traded.
Ratios:
Our goal is to gain a better understanding of ATXI by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.55 and its Current Ratio is at 1.55. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 11 ’23 when Davidow Robert L sold 353,000 shares for $0.14 per share. The transaction valued at 49,600 led to the insider holds 22,000 shares of the business.
Davidow Robert L sold 264,000 shares of ATXI for $36,960 on Dec 11 ’23. The 10% Owner now owns 681,000 shares after completing the transaction at $0.14 per share. On Sep 08 ’23, another insider, Fortress Biotech, Inc., who serves as the 10% Owner of the company, bought 418,410 shares for $0.72 each. As a result, the insider paid 301,255 and bolstered with 1,032,390 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATXI now has a Market Capitalization of 6.53M and an Enterprise Value of 4.75M.
Stock Price History:
Over the past 52 weeks, ATXI has reached a high of $1.36, while it has fallen to a 52-week low of $0.11. The 50-Day Moving Average of the stock is 0.1513, while the 200-Day Moving Average is calculated to be 0.5179.
Shares Statistics:
The stock has traded on average 5.39M shares per day over the past 3-months and 1.2M shares per day over the last 10 days, according to various share statistics. A total of 44.26M shares are outstanding, with a floating share count of 38.53M. Insiders hold about 12.96% of the company’s shares, while institutions hold 2.79% stake in the company. Shares short for ATXI as of Mar 15, 2024 were 313.39k with a Short Ratio of 0.06, compared to 337.74k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.71% and a Short% of Float of 0.71%.
Earnings Estimates
Its stock is currently analyzed by 1 different market analysts. On average, analysts expect EPS of -$0.12 for the current quarter, with a high estimate of -$0.12 and a low estimate of -$0.12, while EPS last year was -$1.35. The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.1 and low estimates of -$0.1.
Analysts are recommending an EPS of between -$0.41 and -$0.41 for the fiscal current year, implying an average EPS of -$0.41. EPS for the following year is -$0.37, with 1 analysts recommending between -$0.37 and -$0.37.
